Evidence map›Paper›PMID 36180388›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2022

Permeability-Engineered Compartmentalization Enables In Vitro Reconstitution of Sustained Synthetic Biology Systems.

Luyao Li, Rong Zhang, Long Chen, Xintong Tian, Ting Li, Bingchun Pu, Conghui Ma, Xiangyang Ji, Fang Ba, Chenwei Xiong and 6 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Reconstituting alternative life using the test-bed of cell-free systems.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Luyao LiSchool of Physical Science and Technology, ShanghaiTech University, Shanghai, 201210, China.
Rong ZhangSchool of Physical Science and Technology, ShanghaiTech University, Shanghai, 201210, China.
Long ChenSchool of Physical Science and Technology, ShanghaiTech University, Shanghai, 201210, China.
Xintong TianSchool of Physical Science and Technology, ShanghaiTech University, Shanghai, 201210, China.
Ting LiState Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai, 200438, China.
Bingchun PuDepartment of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Conghui MaSchool of Physical Science and Technology, ShanghaiTech University, Shanghai, 201210, China.
Xiangyang JiSchool of Physical Science and Technology, ShanghaiTech University, Shanghai, 201210, China.
Fang BaSchool of Physical Science and Technology, ShanghaiTech University, Shanghai, 201210, China.
Chenwei XiongSchool of Physical Science and Technology, ShanghaiTech University, Shanghai, 201210, China.
Yunfeng ShiState Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai, 200438, China.
Xianqiang MiShanghai Institute of Microsystem and Information Technology, Chinese Academy of Sciences, Shanghai, 200050, China.
Jian LiSchool of Physical Science and Technology, ShanghaiTech University, Shanghai, 201210, China.
Jay D KeaslingJoint BioEnergy Institute, Emeryville, CA, 94608, USA.
Jingwei ZhangState Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai, 200438, China.
Yifan LiuSchool of Physical Science and Technology, ShanghaiTech University, Shanghai, 201210, China.ORCID 0000-0002-2989-6280

Funding

National Key R&D Program of China 2020YFA0803800National Natural Science Foundation of China 32070948National Natural Science Foundation of China 61904105National Natural Science Foundation of China 91942313Shanghai Pujiang Talent Program 19PJ1401600
6 · The paper itself

Abstract

In nature, biological compartments such as cells rely on dynamically controlled permeability for matter exchange and complex cellular activities. Likewise, the ability to engineer compartment permeability is crucial for in vitro systems to gain sustainability, robustness, and complexity. However, rendering in vitro compartments such a capability is challenging. Here, a facile strategy is presented to build permeability-configurable compartments, and marked advantages of such compartmentalization are shown in reconstituting sustained synthetic biology systems in vitro. Through microfluidics, the strategy produces micrometer-sized layered microgels whose shell layer serves as a sieving structure for biomolecules and particles. In this configuration, the transport of DNAs, proteins, and bacteriophages across the compartments can be controlled an guided by a physical model. Through permeability engineering, a compartmentalized cell-free protein synthesis system sustains multicycle protein production; ≈100 000 compartments are repeatedly used in a five-cycle synthesis, featuring a yield of 2.2 mg mL

Indexed as

ExerciseSynthetic BiologyMicrofluidicsbiomaterialscell-free protein synthesiscompartmentalizationsynthetic biologywhole-cell biosensors

Identifiers

PMID36180388
PMCPMC9731718

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.